For instance, the correlation coefficient between PRRX1 and CD86, a co-stimulatory molecule on antigen-presenting cells that had been demonstrated to act as a pivotal role in tumor immunity in pancreatic and bladder cancers, reached 0.683 [53, 54]. This evidence concerns the gene PRRX1 and neoplasm.